资讯
来自MSN10 个月
石四药集团(02005.HK):腹膜透析液通过仿制药质量和疗效一致性评价格隆汇5月30日丨石四药集团(02005.HK)公告,集团的腹膜透析液(乳酸盐–G4.25%)(2000ml,含4.25%葡萄糖)已取得中国国家药品监督管理 ...
Hong Kong stocks were little changed on Wednesday, as investors held off on bets ahead of earnings from Tencent Holdings and a Federal Reserve meeting. The Hang Seng Index rose 0.1 per cent to ...
A humanised immunoglobulin G4 monoclonal antibody, sasanlimab works by binding to the programmed death-1 (PD-1) receptor, blocking its interaction with PD-L1/PD-L2. Approximately 100,000 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果